Heterozygous methylenetetrahydrofolate reductase 677C-T gene mutation with mild hyperhomocysteinemia associated with intrauterine iliofemoral artery thrombosis

Blood Coagul Fibrinolysis. 2006 Sep;17(6):495-8. doi: 10.1097/01.mbc.0000240925.03425.c0.

Abstract

Neonatal thrombosis is a serious event that can cause mortality or severe morbidity. Newborn-related factors, including genetic prothrombotic risk factors, may affect the occurrence of neonatal thrombosis. In this report, a case of intrauterine iliofemoral arterial thrombosis associated with mild hyperhomocysteinemia caused by methylenetetrahydrofolate reductase 677C-T gene mutation is presented. We suggest that methylenetetrahydrofolate reductase gene mutation might be investigated in neonates and their families presenting with thromboembolic disease.

Publication types

  • Case Reports

MeSH terms

  • Angioplasty, Balloon
  • Femoral Artery*
  • Fibrinolytic Agents / administration & dosage
  • Heparin / administration & dosage
  • Humans
  • Iliac Artery*
  • Infant, Newborn
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Mutation / genetics*
  • Streptokinase / administration & dosage
  • Thrombosis / enzymology*
  • Thrombosis / genetics
  • Thrombosis / therapy

Substances

  • Fibrinolytic Agents
  • Heparin
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Streptokinase